(MedPage Today) — Screening for heterozygous familial hypercholesterolemia in childhood or early adulthood wouldn’t come close to being cost-effective, despite reducing lifetime cardiovascular disease (CVD) events such as strokes or coronary heart…
Source link : https://www.medpagetoday.com/pediatrics/generalpediatrics/118390
Author :
Publish date : 2025-11-09 22:00:00
Copyright for syndicated content belongs to the linked Source.
